Evidence map›Paper›PMID 28640660›Full record

ArticleNucleus (Austin, Tex.)2017

Chromosome territory relocation paradigm during DNA damage response: Some insights from molecular biology to physics.

Sarosh N Fatakia, Mugdha Kulashreshtha, Ishita S Mehta, Basuthkar J Rao

Open access · goldAbstract readComment
In one paragraph

Article in Nucleus (Austin, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Genome-wide mapping of genomic DNA damage: methods and implications.Cellular and molecular life sciences : CMLS · 2021
    Review
  2. Shaping of the 3D genome by the ATPase machine cohesin.Experimental & molecular medicine · 2020
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarosh N Fatakiaa Department of Biological Sciences, Tata Institute of Fundamental Research , Mumbai , Maharashtra , India.ORCID 0000-0003-0430-3191
Mugdha Kulashreshthaa Department of Biological Sciences, Tata Institute of Fundamental Research , Mumbai , Maharashtra , India.
Ishita S Mehtaa Department of Biological Sciences, Tata Institute of Fundamental Research , Mumbai , Maharashtra , India.
Basuthkar J Raoa Department of Biological Sciences, Tata Institute of Fundamental Research , Mumbai , Maharashtra , India.
Tata Institute of Fundamental Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the many facets of DNA damage response (DDR), relocation of chromosome territories (CTs) is most intriguing. We have previously reported that cisplatin induced DDR in human dermal fibroblasts led to relocation of CTs 12, 15 from the nuclear periphery to its interior while CTs 19, 17 repositioned from the interior to its periphery. Studies of CT relocation remain nascent as we begin unraveling the role of key players in DDR to demonstrate its mechanistic basis. Consolidating our recent reports, we argue that γH2AX-signaling leads to enhanced recruitment of nuclear myosin 1 (NM1) to chromatin, which via its motor function, results in CT repositioning. Next, we invoke a novel systems-level theory that subsumed CTs as pairs, not solo entities, to present the physical basis for plasticity in interphase CT arrangement. Subsequently, we posited that our systems-level theory describes a unified physical basis for non-random positioning of CTs in interphase nuclei across disparate eukaryotes.

Indexed as

Biophysical PhenomenaDNA DamageBiological Transport, ActiveChromosomesFibroblastsHistonesHumansSignal TransductionH2AX protein, humanHistones3D genome organizationcell cyclechromosome territoryCisplatin treatmentCT relocationDDRDNA damageNM1 and Induced DNA damageserum starvationunified genome

Identifiers

PMID28640660
PMCPMC5703250
OpenAlexW2633482922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.